OBJECTIVE: Trichomonas vaginalis infection is the most prevalent treatable sexually transmitted infection (STI) in the world. An accurate point-of-care (PoC) molecular test would enable patients to be tested and treated for T vaginalis in a single visit to the genitourinary medicine clinic, community STI clinic, pharmacy or doctor's office. In this report, we describe a rapid prototype assay for T vaginalis designed for use in conjunction with the Atlas io PoC platform, and initial verification of its performance using 90 clinical samples. METHODS: A rapid prototype T vaginalis assay was designed. The test, featuring novel electrochemical end-point detection, used a multi-copy region of the T vaginalis genome as the assay target. Ninety clinical vaginal swab samples were used to verify the performance of the prototype assay. RESULTS: The assay demonstrated a sensitivity and specificity of 95.5% (42/44) and 95.7% (44/46), respectively, when tested using clinical samples. Assay inclusivity was demonstrated for a number of geographically diverse T vaginalis isolates, and the test showed no cross-reactivity with either human DNA or a panel of DNAs isolated from common cross-reactants. CONCLUSIONS: The sensitivity and specificity achieved using this prototype assay is comparable with that achieved for existing central laboratory nucleic acid amplification tests used for screening patients for T vaginalis.
OBJECTIVE:Trichomonas vaginalisinfection is the most prevalent treatable sexually transmitted infection (STI) in the world. An accurate point-of-care (PoC) molecular test would enable patients to be tested and treated for T vaginalis in a single visit to the genitourinary medicine clinic, community STI clinic, pharmacy or doctor's office. In this report, we describe a rapid prototype assay for T vaginalis designed for use in conjunction with the Atlas io PoC platform, and initial verification of its performance using 90 clinical samples. METHODS: A rapid prototype T vaginalis assay was designed. The test, featuring novel electrochemical end-point detection, used a multi-copy region of the T vaginalis genome as the assay target. Ninety clinical vaginal swab samples were used to verify the performance of the prototype assay. RESULTS: The assay demonstrated a sensitivity and specificity of 95.5% (42/44) and 95.7% (44/46), respectively, when tested using clinical samples. Assay inclusivity was demonstrated for a number of geographically diverse T vaginalis isolates, and the test showed no cross-reactivity with either human DNA or a panel of DNAs isolated from common cross-reactants. CONCLUSIONS: The sensitivity and specificity achieved using this prototype assay is comparable with that achieved for existing central laboratory nucleic acid amplification tests used for screening patients for T vaginalis.
Entities:
Keywords:
DIAGNOSIS; DNA AMPLIFICATION; TRICHOMONAS
Authors: M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads Journal: Sex Transm Dis Date: 1997-07 Impact factor: 2.830
Authors: R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten Journal: J Infect Dis Date: 2007-01-22 Impact factor: 5.226
Authors: Jill S Huppert; Joel E Mortensen; Jennifer L Reed; Jessica A Kahn; Kimberly D Rich; William C Miller; Marcia M Hobbs Journal: Clin Infect Dis Date: 2007-06-06 Impact factor: 9.079
Authors: Yu-Hsiang Hsieh; M Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill Huppert; Anne M Rompalo; Charlotte A Gaydos Journal: PLoS One Date: 2010-11-30 Impact factor: 3.240
Authors: Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake Journal: Sex Transm Infect Date: 2012-09-14 Impact factor: 3.519
Authors: Jane M Carlton; Robert P Hirt; Joana C Silva; Arthur L Delcher; Michael Schatz; Qi Zhao; Jennifer R Wortman; Shelby L Bidwell; U Cecilia M Alsmark; Sébastien Besteiro; Thomas Sicheritz-Ponten; Christophe J Noel; Joel B Dacks; Peter G Foster; Cedric Simillion; Yves Van de Peer; Diego Miranda-Saavedra; Geoffrey J Barton; Gareth D Westrop; Sylke Müller; Daniele Dessi; Pier Luigi Fiori; Qinghu Ren; Ian Paulsen; Hanbang Zhang; Felix D Bastida-Corcuera; Augusto Simoes-Barbosa; Mark T Brown; Richard D Hayes; Mandira Mukherjee; Cheryl Y Okumura; Rachel Schneider; Alias J Smith; Stepanka Vanacova; Maria Villalvazo; Brian J Haas; Mihaela Pertea; Tamara V Feldblyum; Terry R Utterback; Chung-Li Shu; Kazutoyo Osoegawa; Pieter J de Jong; Ivan Hrdy; Lenka Horvathova; Zuzana Zubacova; Pavel Dolezal; Shehre-Banoo Malik; John M Logsdon; Katrin Henze; Arti Gupta; Ching C Wang; Rebecca L Dunne; Jacqueline A Upcroft; Peter Upcroft; Owen White; Steven L Salzberg; Petrus Tang; Cheng-Hsun Chiu; Ying-Shiung Lee; T Martin Embley; Graham H Coombs; Jeremy C Mottram; Jan Tachezy; Claire M Fraser-Liggett; Patricia J Johnson Journal: Science Date: 2007-01-12 Impact factor: 47.728
Authors: Lindi Masson; Kelly B Arnold; Francesca Little; Koleka Mlisana; David A Lewis; Nonhlanhla Mkhize; Hoyam Gamieldien; Sinaye Ngcapu; Leigh Johnson; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore Journal: Sex Transm Infect Date: 2015-10-28 Impact factor: 3.519
Authors: Andrew J Vallely; William S Pomat; Caroline Homer; Rebecca Guy; Stanley Luchters; Glen D L Mola; Grace Kariwiga; Lisa M Vallely; Virginia Wiseman; Chris Morgan; Handan Wand; Stephen J Rogerson; Sepehr N Tabrizi; David M Whiley; Nicola Low; Rosanna Peeling; Peter Siba; Michaela Riddell; Moses Laman; John Bolnga; Leanne J Robinson; Jacob Morewaya; Steven G Badman; Neha Batura; Angela Kelly-Hanku; Pamela J Toliman; Wilfred Peter; Delly Babona; Elizabeth Peach; Suzanne M Garland; John M Kaldor Journal: Wellcome Open Res Date: 2019-03-22